-
3
-
-
0034047385
-
Psoriasis
-
Drew GS. Psoriasis. Prim Care 2000;27(2):385-406
-
(2000)
Prim Care
, vol.27
, Issue.2
, pp. 385-406
-
-
Drew, G.S.1
-
4
-
-
0036621075
-
The direct cost of care for psoriasis and psoriatic arthritis in the United States
-
Javitz HS, Ward MM, Farber E, et al. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002;46(6):850-60
-
(2002)
J Am Acad Dermatol
, vol.46
, Issue.6
, pp. 850-860
-
-
Javitz, H.S.1
Ward, M.M.2
Farber, E.3
-
5
-
-
0036145337
-
The immunologic basis for the treatment of psoriasis with new biologic agents
-
Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002;46(1):1-23
-
(2002)
J Am Acad Dermatol
, vol.46
, Issue.1
, pp. 1-23
-
-
Krueger, J.G.1
-
6
-
-
0034805313
-
Treatment of psoriasis. Part 1: Topical therapy and phototherapy
-
Lebwohl M, Ali S. Treatment of psoriasis. Part 1: topical therapy and phototherapy. J Am Acad Dermatol 2001;45(4):487-98
-
(2001)
J Am Acad Dermatol
, vol.45
, Issue.4
, pp. 487-498
-
-
Lebwohl, M.1
Ali, S.2
-
7
-
-
0034141772
-
Treatment of psoriasis: An algorithm-based approach for primary care physicians
-
Pardasani AG, Feldman SR, Clark AR. Treatment of psoriasis: an algorithm-based approach for primary care physicians. Am Fam Physician 2000;61(3):725-36
-
(2000)
Am Fam Physician
, vol.61
, Issue.3
, pp. 725-736
-
-
Pardasani, A.G.1
Feldman, S.R.2
Clark, A.R.3
-
11
-
-
0034753878
-
Treatment of psoriasis. Part 2: Systemic therapies
-
Lebwohl M, Ali S. Treatment of psoriasis. Part 2: systemic therapies. J Am Acad Dermatol 2001;45(5):649-61
-
(2001)
J Am Acad Dermatol
, vol.45
, Issue.5
, pp. 649-661
-
-
Lebwohl, M.1
Ali, S.2
-
12
-
-
0033957542
-
Advances in psoriasis therapy
-
Lebwohl M. Advances in psoriasis therapy. Dermatol Clin 2000;18(1):13-9
-
(2000)
Dermatol Clin
, vol.18
, Issue.1
, pp. 13-19
-
-
Lebwohl, M.1
-
13
-
-
0026053929
-
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
-
[Erratum, Lancet 1991;337(8747):988]
-
Kragballe K, Gjertsen BT, De Hoop D, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991;337(8735):193-6 [Erratum, Lancet 1991;337(8747):988]
-
(1991)
Lancet
, vol.337
, Issue.8735
, pp. 193-196
-
-
Kragballe, K.1
Gjertsen, B.T.2
De Hoop, D.3
-
14
-
-
85039400499
-
Psoriasis treatments
-
Accessed Jan 3, 2005
-
Psoriasis treatments. Bandolier 1998;51-5. Available at: http://www.jr2.ox.ac.uk/bandolier/band51/b51-5.html. Accessed Jan 3, 2005
-
(1998)
Bandolier
, pp. 51-55
-
-
-
15
-
-
0037947382
-
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeb
-
Weinstein GD, Koo JY, Krueger GG, et al. Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeb. J Am Acad Dermatol 2003;48(5):760-7
-
(2003)
J Am Acad Dermatol
, vol.48
, Issue.5
, pp. 760-767
-
-
Weinstein, G.D.1
Koo, J.Y.2
Krueger, G.G.3
-
16
-
-
0033927791
-
Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel
-
Behrens S, Grundmann-Kollmann M, Schiener R, et al. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol 2000;42(3):493-5
-
(2000)
J Am Acad Dermatol
, vol.42
, Issue.3
, pp. 493-495
-
-
Behrens, S.1
Grundmann-Kollmann, M.2
Schiener, R.3
-
17
-
-
17744374052
-
PUVA follow up study. The risk of melanoma in association with long-term exposure to PUVA
-
Stern RS; PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001;44(5):755-61
-
(2001)
J Am Acad Dermatol
, vol.44
, Issue.5
, pp. 755-761
-
-
Stern, R.S.1
-
18
-
-
0036895587
-
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
-
Krueger GG, Papp KA, Stough DB, et al. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002;47(6):821-33
-
(2002)
J Am Acad Dermatol
, vol.47
, Issue.6
, pp. 821-833
-
-
Krueger, G.G.1
Papp, K.A.2
Stough, D.B.3
-
19
-
-
19944417773
-
Alefacept significantly reduces psoriasis area and severity in people with chronic plaque psoriasis
-
Accessed Jan 3, 2005
-
Ellis C, Krueger GG. Alefacept significantly reduces psoriasis area and severity in people with chronic plaque psoriasis. Evidence-based Healthcare: a Scientific Approach to Health Policy 2002;6(1):39-40. Available at: http://home.mdconsult.com/das/article/body/1/jorg=journal&source=&sp= 12427388&sid=1825. Accessed Jan 3, 2005
-
(2002)
Evidence-based Healthcare: A Scientific Approach to Health Policy
, vol.6
, Issue.1
, pp. 39-40
-
-
Ellis, C.1
Krueger, G.G.2
|